Key result
Adipokines function as active endocrine regulators and biomarkers, with their dysregulation implicated in obesity, type 2 diabetes, hypertension, and cardiovascular disease.
This review highlights the role of adipokines as active endocrine regulators and potential therapeutic targets in metabolic syndrome and cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Adipokine assessment may refine cardiometabolic risk stratification; leaves open whether modulation improves outcomes in obesity-related CVD.
Deng et al. (2010) conducted a review in Metabolic syndrome. Adipokines was evaluated. Adipokines function as active endocrine regulators and biomarkers, with their dysregulation implicated in obesity, type 2 diabetes, hypertension, and cardiovascular disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: